Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected in Denmark.

I dipendenti di Novo avevano previsto tagli di posti di lavoro da quando Mike Doustdar ha assunto la carica di amministratore delegato il mese scorso

Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected in Denmark.